Nephropathy: Clinical Trials

57 trials for Nephropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 10 unknown, 7 recruiting, 7 terminated. 15 Phase 2, 13 Not applicable, 7 Phase 4, 3 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 215Completed 11, Active not recruiting 1, Not yet recruiting 1, Terminated 1, Withdrawn 1
Not applicable13Completed 6, Unknown 3, Terminated 2, Not yet recruiting 1, Recruiting 1
Phase 47Unknown 3, Completed 2, Recruiting 1, Terminated 1
Phase 13Completed 2, Active not recruiting 1
Phase 33Completed 2, Terminated 1
Early Phase 11Recruiting 1

Follow Nephropathy: new trials by email Literature Review of Nephropathy trials Research Report on Nephropathy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals at Risk of Nephropathy
Nephropathy, Opportunistic Viral Infection
RecruitingUniversity Hospital, Grenoble1002026-03-112026-05-27
A Study of Mitapivat in Participants With Sickle Cell Disease and Nephropathy
Mitapivat - Sickle Cell Disease, Nephropathy
Phase 2WithdrawnAgios Pharmaceuticals, Inc.2026-03-012026-04-03
Salivary Replication of BK Virus in Post-kidney Transplant
Salivary self-collection - BK Virus, Salivary Replication
Not applicableNot yet recruitingCentre Hospitalier Universitaire, Amiens1002025-12-012025-12-08
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
observational study - Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
RecruitingJaeb Center for Health Research2002025-09-182026-02-10
Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia
Sotagliflozin, Placebo - Nephropathy, Diabetic Nephropathies
Phase 2Not yet recruitingSteno Diabetes Center Copenhagen692025-02-012025-01-27
Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy
Sacubitril/Valsartan, Valsartan - Essential Hypertension, Type 2 Diabetes
Phase 4UnknownSichuan Academy of Medical Sciences2972024-08-012024-07-15
An Exploratory Clinical Study of Anti-CD19 CAR NK Cell (KN5501) in the Treatment of Relapsed/Refractory Immune Nephropathy
anti-CD19 CAR NK cells - Nephropathy
Early Phase 1RecruitingChanghai Hospital362024-06-212026-06-26
Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy
Huaier granule, Renin-angiotensin-aldosterone system inhibitors (RASI), Ciclosporin soft capsules - Nephropathy, Glomerular Diseases
Phase 4RecruitingChinese PLA General Hospital4802023-05-092024-06-04
The Role of Renal Progenitors and Polyploid Tubular Cell Response in Glomerular and Tubular Diseases
Study of renal progenitors - Nephropathy
Not applicableRecruitingMeyer Children's Hospital IRCCS2002023-03-222024-03-22
Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation
Brincidofovir - BK Virus Infection, Nephropathy
Phase 2TerminatedSymBio Pharmaceuticals12022-10-142024-12-04
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Aminohippurate Sodium Inj 20%, Iohexol Inj 300 MG/ML, Dextran 40 - Type 2 Diabetes, Diabetes Type 2
CompletedUniversity of Colorado, Denver572022-09-302026-08-24
The Role of Ultrasonography in Predicting Outcomes of Fetal Nephropathy
Nephropathy
CompletedIRCCS Azienda Ospedaliero-Universitaria di Bologna1902022-01-032025-02-04
Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia
Blood sample - BK Virus Infection, Nephropathy
UnknownAssistance Publique - Hôpitaux de Paris412021-09-022024-04-03
Neonatal Outcome of Children With Antenatal Colic Hyperechogenicity
Colic, Nephropathy
UnknownUniversity Hospital, Montpellier4002021-07-012021-11-15
Development of Synthetic Medical Data Generation Technology to Predict Postoperative Complications
Acute Kidney Injury, Surgery-Complications
CompletedSeoul National University Hospital4100002021-03-262023-08-14
Clinical Trial of Anti-PLA2R-IgG Detection Kit (Time-resolved Fluorescence Immunoassay)
Nephropathy
CompletedZhejiang University2192021-03-012024-06-13
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients
Cisplatin injection - Non Small Cell Lung Cancer, Nephropathy
UnknownAin Shams University1782020-07-012023-02-28
Effects of Probiotics and Fibers on Albuminuria in Persons With Type 1 Diabetes
Pro-/prebiotic Mix, Placebo - Type 1 Diabetes, Nephropathy
Not applicableCompletedSteno Diabetes Center Copenhagen412020-06-292023-10-30
Acute Effects of SGLT2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 Diabetes
Forxiga - Nephropathy, Hypoxia
Phase 4CompletedSteno Diabetes Center Copenhagen302020-02-012021-02-03
Screening for Fabry Disease in Renal Transplantation
Screening for Fabry disease, Screen for α-galactosidase mutation - Fabry Disease, Nephropathy
TerminatedUniversity Hospital, Montpellier5922019-03-252025-05-16

Showing 20 of 57. Sign in to see all of them.

Narrower conditions

Kidney Diseases (57)  ·  Diabetes Mellitus, Type 2 (9)  ·  Diabetic Nephropathies (7)  ·  Diabetes Mellitus (6)  ·  Cardiovascular Diseases (4)  ·  Diabetes Complications (4)  ·  Diabetes Mellitus, Type 1 (4)  ·  Obesity (4)  ·  Acute Kidney Injury (3)  ·  Pediatric Obesity (3)  ·  Retinal Diseases (3)  ·  Albuminuria (2)  ·  Anemia, Sickle Cell (2)  ·  Diabetic Neuropathies (2)  ·  Hypoxia (2)

Broader conditions

Female Urogenital Diseases (57)  ·  Female Urogenital Diseases and Pregnancy Complications (57)  ·  Male Urogenital Diseases (57)  ·  Urogenital Diseases (57)  ·  Urologic Diseases (56)  ·  Metabolic Diseases (20)  ·  Nutritional and Metabolic Diseases (20)  ·  Endocrine System Diseases (18)  ·  Glucose Metabolism Disorders (18)  ·  Diabetes Mellitus (13)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Signs and Symptoms (9)  ·  Cardiovascular Diseases (6)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Diabetes Complications (6)

Interventions

Atorvastatin (4)  ·  Iohexol (4)  ·  p-Aminohippuric Acid (4)  ·  Losartan (3)  ·  Saline Solution, Hypertonic (3)  ·  Sodium Chloride (2)  ·  Tolvaptan (2)  ·  Valsartan (2)  ·  (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (1)  ·  Acetylcysteine (1)  ·  Atrasentan (1)  ·  Bariatric Surgery (1)  ·  Blood Specimen Collection (1)  ·  Cisplatin (1)  ·  Dandshen (1)

Sponsors

Regional Hospital Holstebro (6)  ·  Steno Diabetes Center Copenhagen (4)  ·  University of Colorado, Denver (4)  ·  Erling Bjerregaard Pedersen (2)  ·  University Hospital, Montpellier (2)  ·  AbbVie (1)  ·  Agios Pharmaceuticals, Inc. (1)  ·  Agnieszka Pozdzik (1)  ·  Ain Shams University (1)  ·  Ali Aminian (1)  ·  Assaf-Harofeh Medical Center (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Changhai Hospital (1)

Countries

United States (13)  ·  Denmark (11)  ·  China (8)  ·  France (7)  ·  Italy (3)  ·  Canada (2)  ·  Israel (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Egypt (1)  ·  Germany (1)  ·  Iran (1)  ·  Japan (1)  ·  Puerto Rico (1)  ·  South Korea (1)

Top investigators

Petter Bjornstad, MD (4)  ·  Frank H Christensen, MD (2)  ·  Brandy A Wicklow, MD, MSc (1)  ·  Brendan Keating, DPhil (1)  ·  Erling B Pedersen, DMSc (1)  ·  Erling B Pedersen, MD, DMSc (1)  ·  Erling B Pedersen, Professor (1)  ·  Frank H Mose, MD, PhD (1)  ·  Gianluigi Pilu, MD (1)  ·  Guillaume Mahe, MD (1)  ·  Haiming Shi, Professor (1)

Results publications

PMID 32737116, PMID 35507146, PMID 38018702, PMID 38682786, PMID 19829124, PMID 20647424, PMID 21542122, PMID 21632472, PMID 21791335, PMID 21997396, PMID 22695330, PMID 24067081, PMID 24206457, PMID 24256611, PMID 24552328, PMID 24970686, PMID 25014549, PMID 25157242, PMID 25284698, PMID 25530085, PMID 26802296, PMID 28288570, PMID 28589652, PMID 29802538, PMID 30445841, PMID 30693275, PMID 32567439, PMID 32729273, PMID 32750455, PMID 34386735, PMID 35387874, PMID 35391843, PMID 36573119, PMID 36623423, PMID 37872654, PMID 39147695, PMID 39382091, PMID 39656268, PMID 39819994, PMID 39831175, PMID 40526444, PMID 40548378, PMID 40569673, PMID 40828617, PMID 41708511, PMID 42224366

NIH funding

2016 (2), 2019 (1), 2023 (1), R01HD091185 (1)